Alain U. Vetterli
Director Ejecutivo en A&M Corp. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Garry Paul McCann | M | 63 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 años |
Peter B. Hirshfield | M | 78 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Vardakis | M | 59 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 años |
Matthew C. Lords | M | 55 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 años |
Robert Lawrence Banner | M | 80 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 1 años |
Ian Ilsley | M | 75 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 6 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Alain U. Vetterli
- Red Personal